Microbubble Contrast Media Market Size, Share, Trends, Application, Business Growth. Demand, Forecast and Challenges

Data Bridge Market Research has recently published a Report, titled, “Global Microbubble Contrast Media Market” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter’s Five Forces analysis, and competitive landscape.

The use of microbubble contrast agents in ultrasound imaging for general tissue delineation and perfusion is gaining popularity. Microbubbles, as contrast materials, have a low dosage requirement and excellent detection sensitivity. Targeting ligands on the surface of microbubbles allow for the selective accumulation of these particles in areas of interest that have an increased level of receptor molecules on vascular endothelium. These goods aid in determining the need of preoperative scans before the operations and therapy in interventional procedures, which is expected to help the market growth of microbubble contrast media.

Data Bridge Market Research analyses that the microbubble contrast media market which is expected to at a healthy CAGR during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microbubble-contrast-media-market

Market Overview:

Contrast media, also known as contrast agents, is a substance that is usually transparent to X-rays and is used in medical imaging to speed up the contrast of fluids or structures. Microbubbles are used as a blood pool agent for contrast ultrasound imaging in cardiology and radiology. They are widely used in gene therapy, stem cell delivery, drug delivery, molecular imaging, and other applications. Microbubbles can also be used in conjunction with ligand molecules that target molecular markers of disease. The main purpose of microbubble-based ultrasound contrast agents is to monitor the biomarker condition of vascular endothelium, image inflammation, and visualise tumour vasculature, among other things.

Drivers

• Increasing image-guided surgeries

Image-guided surgeries (IGS) are gaining popularity. These procedures can be used to diagnose and treat a variety of conditions. The growing need and demand for imaging refinement during surgeries necessitates novel methods of data acquisition, processing, and display, as well as a thorough understanding of the imaging process and its applications in therapy. This need is very well served by image-guided procedures, which has resulted in increased demand for image-guided procedures for diagnostics and treatment, and thus has served as a market growth factor.

• Increasing prevalence of complex comorbidities

The increasing prevalence of complex comorbidities and chronic diseases has increased diagnostic imaging tests such as ultrasound, X-rays, and advanced imaging technology such as MRI and CT scans. For instance, GE Healthcare received FDA approval for Clariscan, a contrast agent used in macrocyclic MRI in November 2019. These products aid in the identification of the need for perioperative scans prior to surgeries and treatment in interventional procedures, which is expected to drive market growth.

Recent developments

• In February 2022, Lopamidal by Beijing Beilu Pharmaceuticals passed the generic drug Consistency Evaluation. The evaluation aids in comparing the quality and efficacy of generic drugs to the brand version of the drug.
• In July 2020, Bayer and Siemens Healthineers presented a new Imaging System Interface (ISI) for magnetic resonance imaging. The Interface combines the Bayer MRXperion MR Injection System and the Siemens Healthineers MR scanner to overcome the limitations of the traditional method.

Some of the major players operating in the microbubble contrast media market are:

• Lantheus (U.S.)
• Bracco Imaging S.p.A. (Italy)
• General Electric (U.S.)
• DAIICHI SANKYO COMPANY, LIMITED (Japan)
• nanoPET Pharma GmbH (Germany)
• Trust Bio-sonics (Taiwan)
• FUJIFILM VisualSonics Inc. (Canada)
• Trivitron Healthcare (India)
• Siemens (Germany)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@  https://www.databridgemarketresearch.com/reports/global-microbubble-contrast-media-market

Global Microbubble Contrast Media Market Scope

Therapeutic Area

• Cardiovascular Diseases
• Renal and Associated Diseases
• Others

 Application

• Molecular Imaging
• Gene Therapy
• Drug Delivery
• Stem Cells Delivery

Route of Administration

• Rectal
• Oral
• Injectable

 Form

• Tablet
• Powder
• Liquid
• Paste

Procedures

• X-ray/Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)

Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-microbubble-contrast-media-market

Top DBMR Healthcare Reports:         

https://www.databridgemarketresearch.com/reports/global-retinal-vein-occlusion-market

https://www.databridgemarketresearch.com/reports/global-yellow-fever-treatment-market

https://www.databridgemarketresearch.com/reports/global-atherectomy-systems-market

https://www.databridgemarketresearch.com/reports/pain-management-devices-market

https://www.databridgemarketresearch.com/reports/global-end-stage-renal-disease-esrd-drug-market

https://www.databridgemarketresearch.com/reports/global-emphysema-drug-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com